Skip to main content
Signal8
Grosswald Ralph profile photo

Ralph Grosswald

CIK: 0001826084

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Dogwood Therapeutics, Inc. logo
DWTX

Dogwood Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Dogwood Therapeutics, Inc. logo
    DWTX

    Dogwood Therapeutics, Inc.

    Mar 5, 2026
    Award(A)

    Stock Option (right to buy)

    Direct
    82.5K shares-
  • Dogwood Therapeutics, Inc. logo
    DWTX

    Dogwood Therapeutics, Inc.

    Dec 4, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    150K shares-
  • Dogwood Therapeutics, Inc. logo
    DWTX

    Dogwood Therapeutics, Inc.

    Jun 27, 2025
    Award(A)

    Stock Option (right to buy)

    Direct
    12.1K shares-

1-3 of 3

About Grosswald Ralph

Grosswald Ralph (SEC CIK 0001826084) files insider reports with the SEC as SVP OF OPERATIONS of Dogwood Therapeutics, Inc. (DWTX).

Signal8 holds 3 ownership filings by Grosswald Ralph, all Form 4s, filed between Jul 1, 2025 and Mar 6, 2026. Those filings report 3 transactions, from Jun 27, 2025 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Grosswald Ralph's filings is in ALPHARETTA, GA.

Recent filings by Grosswald Ralph

  • Mar 5, 2026: Grant or award of DWTX derivative securities (Form 4, code A).
  • Dec 4, 2025: Grant or award of DWTX derivative securities (Form 4, code A).
  • Jun 27, 2025: Grant or award of DWTX derivative securities (Form 4, code A).

Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)

How to read Form 4 transaction codes